Portal de Periódicos da CAPES

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries

2021; Oxford University Press; Volume: 60; Issue: SI Linguagem: Inglês

10.1093/rheumatology/keab250

1462-0332

Eng Hooi Tan, Anthony G. Sena, Albert Prats‐Uribe, Seng Chan You, Waheed‐Ul‐Rahman Ahmed, Kristin Kostka, Christian Reich, Scott L. DuVall, Kristine E. Lynch, Michael E. Matheny, Talita Duarte‐Salles, Sergio Fernández‐Bertolín, George Hripcsak, Karthik Natarajan, Thomas Falconer, Henry M. Spotnitz, Anna Ostropolets, Clair Blacketer, Thamir M. Alshammari, Heba Alghoul, Osaid Alser, Jennifer C. E. Lane, Dalia Dawoud, Karishma Shah, Yue Yang, Lin Zhang, Carlos Areia, Asieh Golozar, Martina Recalde, Paula Casajust, Jitendra Jonnagaddala, Vignesh Subbian, David Vizcaya, Lana Yin Hui Lai, Fredrik Nyberg, Daniel R. Morales, Jose Posada, Nigam H. Shah, Mengchun Gong, Arani Vivekanantham, Aaron Abend, Evan Minty, Marc A. Suchard, Peter R. Rijnbeek, Patrick Ryan, Daniel Prieto‐Alhambra,

SARS-CoV-2 and COVID-19 Research

Patients with autoimmune diseases were advised to shield to avoid coronavirus disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-day outcomes and mortality after hospitalization with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza.